Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Shares Repurchased (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Shares Repurchased data on record, last reported at $11.0 million in Q1 2025.

  • For Q1 2025, Shares Repurchased fell 69.44% year-over-year to $11.0 million; the TTM value through Sep 2025 reached $61.0 million, changed N/A, while the annual FY2024 figure was $173.0 million, 424.24% up from the prior year.
  • Shares Repurchased reached $11.0 million in Q1 2025 per INDV's latest filing, down from $50.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $52.0 million in Q3 2024 and bottomed at $11.0 million in Q1 2025.